BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11410513)

  • 21. Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth.
    Rapa I; Volante M; Cappia S; Rosas R; Scagliotti GV; Papotti M
    Am J Clin Pathol; 2006 Jun; 125(6):847-54. PubMed ID: 16690483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
    Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
    J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
    Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
    Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchioloalveolar carcinoma of mixed mucinous and nonmucinous type: immunohistochemical studies and mutation analysis of the p53 gene.
    Sato K; Ueda Y; Shikata H; Katsuda S
    Pathol Res Pract; 2006; 202(10):751-6. PubMed ID: 16959434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component.
    Zhong WZ; Wu YL; Yang XN; Guo AL; Su J; Zhang XC; Luo DL; Wang Z; Chen HJ; Zhou Q; Xu CR; Qiao GB; Liao RQ; Yang JJ; Mok TS
    Clin Lung Cancer; 2010 May; 11(3):160-8. PubMed ID: 20439191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytopathologic factors can predict invasion in small-sized peripheral lung adenocarcinoma with a bronchioloalveolar carcinoma component.
    Maezawa N; Tsuta K; Shibuki Y; Yamazaki S; Maeshima AM; Watanabe S; Matsuno Y
    Cancer; 2006 Dec; 108(6):488-93. PubMed ID: 17096436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
    Seki N; Takasu T; Mandai K; Nakata M; Saeki H; Heike Y; Takata I; Segawa Y; Hanafusa T; Eguchi K
    Clin Cancer Res; 2002 Oct; 8(10):3046-53. PubMed ID: 12374671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.
    Riquet M; Foucault C; Berna P; Assouad J; Dujon A; Danel C
    Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
    Willmore-Payne C; Holden JA; Layfield LJ
    Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of cigarette smoking on prognosis in small adenocarcinomas of the lung: the association between histologic subtype and smoking status.
    Sakao Y; Miyamoto H; Oh S; Takahashi N; Inagaki T; Miyasaka Y; Akaboshi T; Sakuraba M
    J Thorac Oncol; 2008 Sep; 3(9):958-62. PubMed ID: 18758296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophils promote aerogenous spread of lung adenocarcinoma with bronchioloalveolar carcinoma features.
    Wislez M; Antoine M; Rabbe N; Gounant V; Poulot V; Lavolé A; Fleury-Feith J; Cadranel J
    Clin Cancer Res; 2007 Jun; 13(12):3518-27. PubMed ID: 17575214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The occurrence of bronchioloalveolar lung cancer among our patients].
    Furák J; Troján I; Szôke T; Tiszlavicz L; Morvay Z; Balogh A
    Magy Onkol; 2003; 47(4):349-53. PubMed ID: 14716429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OCT4 expression in human non-small cell lung cancer: implications for therapeutic intervention.
    Karoubi G; Gugger M; Schmid R; Dutly A
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):393-7. PubMed ID: 19126554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-BAC component but not epidermal growth factor receptor gene mutation is associated with poor outcomes in small adenocarcinoma of the lung.
    Kobayashi N; Toyooka S; Ichimura K; Soh J; Yamamoto H; Matsuo K; Otani H; Jida M; Kubo T; Tsukuda K; Kiura K; Sano Y; Date H
    J Thorac Oncol; 2008 Jul; 3(7):704-10. PubMed ID: 18594314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistopathological re-evaluation of adenocarcinoma of the lung with mixed subtypes using a tissue microarray technique and hierarchical clustering analysis.
    Gamal G; Sano T; Sakurai S; Kawashima O; Sugano M; Nakajima T
    Pathol Int; 2007 Dec; 57(12):765-74. PubMed ID: 17988277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. let-7 microRNA expression is reduced in bronchioloalveolar carcinoma, a non-invasive carcinoma, and is not correlated with prognosis.
    Inamura K; Togashi Y; Nomura K; Ninomiya H; Hiramatsu M; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y
    Lung Cancer; 2007 Dec; 58(3):392-6. PubMed ID: 17728006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A correlation between mutation of the p53 gene and histological heterogeneity in differentiated adenocarcinomas of the lung, with reference to stepwise progression and metastatic ability.
    Yoshida Y
    Hiroshima J Med Sci; 1994 Mar; 43(1):13-21. PubMed ID: 8014071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin.
    Tsuta K; Ishii G; Nitadori J; Murata Y; Kodama T; Nagai K; Ochiai A
    J Pathol; 2006 May; 209(1):78-87. PubMed ID: 16463270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a low risk subgroup of stage IB lung adenocarcinoma patients.
    Mizuno T; Ishii G; Nagai K; Yoshida J; Nishimura M; Mochizuki T; Kawai O; Hasebe T; Ochiai A
    Lung Cancer; 2008 Dec; 62(3):302-8. PubMed ID: 18486987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological characteristics of primary lung adenocarcinoma predominantly composed of goblet cells in surgically resected cases.
    Ichinokawa H; Ishii G; Nagai K; Yoshida J; Nishimura M; Hishida T; Suzuki K; Ochiai A
    Pathol Int; 2011 Jul; 61(7):423-9. PubMed ID: 21707846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.